Earnings Wrinkle SKIN, But Turnaround Treatments Could Revitalize Stock

Weak device sales continue to weigh on Beauty Health Co.'s (SKIN) outlook, but a return to sales growth and profitability by the end of 2024 remains in the cards for the maker of the popular Hydrafacial skin health products.